Patent · US Active

Method of forming dendritic cells from embryonic stem cells

US8435785B2 · kind B2 · utility

2Cited by
7References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2012
Grant dateMay 7, 2013
Priority date
Expiry dateFeb 1, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2506/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to the culture of dendritic cells from human embryonic stem (ES) cells. Human ES cells are first cultured into hematopoietic cells by co-culture with stromal cells. The cells now differentiated into the hematopoietic lineage are then cultured with GM-CSF to create a culture of myeloid precursor cells. Culture of the myeloid precursor cells with the cytokines GM-CSF and IL-4 causes functional dendritic cells to be generated. The dendritic cells have a unique phenotype, as indicated by their combination of cell surface markers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.